SEC Form 4 · accession 0001127602-18-010168
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luke A Pomilio
Other
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2018 | M | 600 | $0.00 | A | 600 | D | |
| Common Stock | Mar 1, 2018 | F | 252 | $59.96 | D | 348 | D | |
| Common Stock | Mar 1, 2018 | M | 650 | $0.00 | A | 998 | D | |
| Common Stock | Mar 1, 2018 | F | 273 | $59.96 | D | 725 | D | |
| Common Stock | Mar 1, 2018 | M | 10,020 | $39.87 | A | 10,745 | D | |
| Common StockF1 | Mar 1, 2018 | S | 10,020 | $60.1959 | D | 725 | D | |
| Common Stock | Mar 1, 2018 | M | 9,600 | $41.93 | A | 10,325 | D | |
| Common StockF1 | Mar 1, 2018 | S | 9,600 | $60.1886 | D | 725 | D | |
| Common Stock | Mar 2, 2018 | S | 725 | $60.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F2 | $0.00 | Mar 1, 2018 | M | 600 | D | — | Feb 27, 2025 | Common Stock | 600 | 600 | D |
| Rsus (restricted Stock Units)F3 | $0.00 | Mar 1, 2018 | M | 650 | D | — | Mar 1, 2026 | Common Stock | 650 | 1,300 | D |
| Options To Purchase Common StockF4 | $39.87 | Mar 1, 2018 | M | 10,020 | D | — | Mar 1, 2026 | Common Stock | 10,020 | 30,060 | D |
| Options To Purchase Common StockF4 | $41.93 | Mar 1, 2018 | M | 9,600 | D | — | Mar 1, 2027 | Common Stock | 9,600 | 38,400 | D |
Explanation of responses
- F1Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- F3Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- F4The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period